Publicaciones en colaboración con investigadores/as de Universidad de Sevilla (16)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Circular and L50-like leaderless enterocins share a common ABC-transporter immunity gene

    BMC Genomics, Vol. 24, Núm. 1

2022

  1. Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival

    Viruses, Vol. 14, Núm. 9

  2. PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer

    Cellular Oncology, Vol. 45, Núm. 2, pp. 323-332

2016

  1. Absence of WASp enhances hematopoietic and megakaryocytic differentiation in a human embryonic stem cell model

    Molecular Therapy, Vol. 24, Núm. 2, pp. 342-353

2014

  1. Peripheral nerve reconstruction with epsilon-caprolactone conduits seeded with vasoactive intestinal peptide gene-transfected mesenchymal stem cells in a rat model

    Journal of Neural Engineering, Vol. 11, Núm. 4

2010

  1. Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels

    Molecular and Cellular Biology, Vol. 30, Núm. 10, pp. 2537-2551

2009

  1. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

    Gut, Vol. 58, Núm. 7, pp. 929-939

  2. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide

    Journal of Immunology, Vol. 183, Núm. 7, pp. 4346-4359

2008

  1. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis

    Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1026-1037

2007

  1. Emerging roles of vasoactive intestinal peptide: A new approach for autoimmune therapy

    Annals of the Rheumatic Diseases

  2. HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination

    Cancer Immunology, Immunotherapy, Vol. 56, Núm. 5, pp. 709-717

  3. Tuning immune tolerance with vasoactive intestinal peptide: A new therapeutic approach for immune disorders

    Peptides, Vol. 28, Núm. 9, pp. 1833-1846

2002

  1. Impact of HLA class I alterations in cancer patients undergoing T cell specific immunotherapy

    TISSUE ANTIGENS

2001

  1. Analysis of 31 CFTR mutations in 55 families from the south of Spain

    Early Human Development

1998

  1. High incidence of H-ras mutations in laryngeal cancer in Spain

    Medical Science Research, Vol. 26, Núm. 4, pp. 279-281